Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Ferring signs licensing agreement with Seikagaku for condoliase

Aug. 29, 2016

Researchers from Genentech identify novel potent and selective NIK inhibitors

Aug. 26, 2016

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Aug. 24, 2016

Novel compound E-6887 shows promise for treating lupus

Aug. 24, 2016

Gilead begins phase III program for filgotinib in rheumatoid arthritis

Aug. 23, 2016

Medshine Discovery discloses JAK inhibitors

Aug. 12, 2016

MPC-300-IV shows dose-related improvements in phase II trial in biologic refractory RA

Aug. 11, 2016

Ablynx reports topline phase IIb results for vobarilizumab in patients with rheumatoid arthritis

Aug. 10, 2016

Autologous BMC is safe and effective in treating patients with atrophic non-unions

Aug. 8, 2016

Omeros' lead MASP-3 inhibitor shows efficacy in arthritis model

Aug. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...